Kerrisdale Advisers’s Accretive Health AH Stock Holding History

Kerrisdale Advisers’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-169,282	Closed	-$1.35M	–	54
2014 Q1	$1.35M	Buy	+169,282	New	+$1.5M	0.67%	24

Other funds holding AH

Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return

Neuberger Berman Group

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return

Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return

EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Merion Investment Management Bay Harbor Islands, Florida $1.26M AUM 28.57% 1-Year Est. Return

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Stonebridge Capital Management Los Angeles, California $208M AUM

Kerrisdale Advisers's AH Position: Q2 2014 in Review

Kerrisdale Advisers sold out of Accretive Health (AH) in Q2 2014, closing a stake of 169,282 shares — an estimated $1.35M sold.

Kerrisdale Advisers first reported a position in AH in Q1 2014 and held it in 1 quarter. The position peaked at $1.35M in Q1 2014. 12 funds tracked by Wall St. Rank hold AH as of Q2 2014.

Kerrisdale Advisers reported no remaining Accretive Health position as of Q2 2014 after selling out during the quarter.
Kerrisdale Advisers sold 169,282 Accretive Health shares in Q2 2014, an estimated $1.35M.
Kerrisdale Advisers first reported a position in Accretive Health in Q1 2014 and held it in 1 quarter.
Kerrisdale Advisers's Accretive Health position peaked at $1.35M in Q1 2014.
12 funds tracked by Wall St. Rank held Accretive Health as of Q2 2014.

Based on Kerrisdale Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.